Nathan Misel, PA
Physician Assistant · Belpre, OHNPI 1558557165
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,908 of the $19,114 with a category attached, or 62.3%. It is spread thinly across 29 manufacturers, the largest accounting for just 17.5%. Reporting peaked in 2024 at $8,987 and has fallen 80.5% since, to $1,755 in 2025. Among physician assistant clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 755 payments — averaging $25.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$3K
- Sanofi$3K
- Johnson & Johnson$2K
- Regeneron Healthcare Solutions, Inc.$2K
- AbbVie$2K
- Amgen$1K
- plus $5K from 23 others
What the payments were for
- Consulting fees$3,36718%
- Speaking & faculty fees$2,12811%
- Travel & lodging$1,0726%
- Food & beverage$11,90862%
- Education$6393%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 51 | $3,340 |
| Sanofi | 32 | $2,843 |
| Johnson & Johnson(2 entities) | 101 | $2,377 |
| Regeneron Healthcare Solutions, Inc. | 61 | $2,267 |
| AbbVie | 130 | $2,000 |
| Amgen | 73 | $1,089 |
| Lilly USA, LLC | 64 | $1,037 |
| Novartis | 37 | $649 |
| Incyte Corporation | 36 | $619 |
| Sun Pharmaceutical Industries Inc. | 33 | $532 |
| Pfizer | 23 | $341 |
| UCB, Inc. | 15 | $293 |
| Dermavant Sciences, Inc. | 18 | $280 |
| Galderma Laboratories, L.p. | 21 | $246 |
| Arcutis Biotherapeutics, Inc. | 9 | $209 |
| Mayne Pharma Commercial LLC | 10 | $154 |
| LEO Pharma Inc. | 7 | $130 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 8 | $118 |
| Biofrontera Inc. | 8 | $111 |
| Janssen Scientific Affairs, LLC | 1 | $104 |
| Sanofi-aventis U.S. LLC | 1 | $70 |
| Merz North America, Inc. | 2 | $69 |
| Boehringer Ingelheim | 3 | $59 |
| Organon | 3 | $41 |
| Verrica Pharmaceuticals Inc. | 2 | $38 |
| VYNE Pharmaceuticals Inc. | 2 | $35 |
| Journey Medical Corporation | 2 | $24 |
| Dermira, Inc. | 1 | $19 |
| Almirall LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,114 in reported general payments places this provider in the 95th percentile of 4,098 physician assistant providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 16 | $352,692 |
| Dupixent PenDupilumab | 59 | $224,356 |
| OdomzoSonidegib Phosphate | 15 | $199,081 |
| Cosentyx (2 Syringes)Secukinumab | 13 | $178,227 |
| OtezlaApremilast | 34 | $160,727 |
| Taltz AutoinjectorIxekizumab | 14 | $96,880 |
| SotyktuDeucravacitinib | 11 | $72,244 |
| RinvoqUpadacitinib | 11 | $65,817 |
| Dupixent SyringeDupilumab | 17 | $62,580 |
| AdbryTralokinumab-Ldrm | 16 | $60,223 |
| Clobetasol Propionate | 122 | $5,791 |
| Mupirocin | 404 | $2,327 |
| Metronidazole | 28 | $2,056 |
| Desoximetasone | 24 | $1,896 |
| Betamethasone Dipropionate | 63 | $1,880 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisCosentyx (2 Syringes) | $649 | $178,22713 claims |
| AmgenOtezla | $1,089 | $160,72734 claims |
| E.r. Squibb & Sons, L.L.C.Sotyktu | $3,340 | $72,24411 claims |
| AbbVieRinvoq | $2,000 | $65,81711 claims |
| LEO Pharma Inc.Adbry | $130 | $60,22316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,098 physician assistant providers in Ohio.
Other physician assistant in Belpre
- Erin StrculaBelpre$106K
- Steven WurzelbacherCincinnati$309K
- Emily AnkromDayton$192K
- Amanda MaggartWorthington$164K
- Megan SevillaMayfield Heights$132K
- Sarah LaubNew Albany$100K
- Jessica RhominskiCanal Winchester$78K
- Brook GramBeloit$52K
- Alison FleigToledo$48K
- Alicia PerkinsColumbus$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.